Skip to main content
OpenTrials

Clinical trial condition

Anemia, Sickle Cell

Explore clinical trials studying Anemia, Sickle Cell. Study availability and eligibility vary by location and protocol.

843 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Sickle Cell trial results

Completed

Pharmacokinetics of Oral Hydroxyurea Solution

NCT03763656

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • Dr Angela E Rankine- Mullings Kingston, Jamaica
  • Birmingham Women's and Children's NHS Foundation Trust Birmingham, United Kingdom
  • Alder Hey Children's NHS Foundation Trust Liverpool, United Kingdom
  • Evelina London Children's Hospital London, United Kingdom
View Trial Details
Completed

Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age

NCT04893811

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Fakultni Nemocnice Brno - Detska Nemocnice - Klinika Detskych Infekcnich Nemoci Center 3 Brno, Czechia
  • Fakultni Nemocnice Brno - Detska Nemocnice - Klinika Detskych Infekcnich Nemoci Center 3 Brno, Czechia
  • Fakultni nemocnice v Motole Prague, Czechia
  • IN-VIVO Sp. z o.o. Bydgoszcz, Poland
View all 14 locations
View Trial Details
Completed

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

NCT03264989

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Novartis Investigative Site Orange, Florida, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Childrens Healthcare of Atlanta . Atlanta, Georgia, United States
  • Augusta University Georgia Patient Treatment Augusta, Georgia, United States
View Trial Details
Completed

Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

NCT04053764

Conditions
Albuminuria, Anemia, Anemia, Hemolytic, +24 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Illinois Hospital and Health Sciences System . Chicago, Illinois, United States
  • Our Lady of the Lake Regional Medic . Baton Rouge, Louisiana, United States
  • East Carolina University BrodySchool of Med 3 Greenville, North Carolina, United States
View all 24 locations
View Trial Details
Completed

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

NCT05098028

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Bausch Site 105 Orange, California, United States
  • Bausch Site 103 Denver, Colorado, United States
  • Bausch Site 104 Atlanta, Georgia, United States
  • Bausch Site 101 Syracuse, New York, United States
View Trial Details
Completed

LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)

NCT03593395

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Health System Mobile, Alabama, United States
  • University of Miami Miami, Florida, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 14 locations
View Trial Details
Completed

Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease

NCT01389024

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Mercy Children's Hospital Kansas City, Missouri, United States
  • St. Louis Children's Hospital St Louis, Missouri, United States
View Trial Details

Related conditions